DNA-based immunization against hepatitis B virus.
Davis
H L
HL
Loeb Research Institute, Ottawa Civic Hospital, Canada.
Brazolot Millan
C L
CL
D000818:Animals; D000831:Animals, Newborn; D002648:Child; D005069:Evaluation Studies as Topic; D005260:Female; D005822:Genetic Vectors; D006509:Hepatitis B / Q000191:economics / Q000276:immunology / Q000517:prevention & control* / Q000635:transmission; D006510:Hepatitis B Antibodies / Q000096:biosynthesis; D006514:Hepatitis B Surface Antigens / Q000235:genetics / Q000276:immunology; D017325:Hepatitis B Vaccines / Q000191:economics / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007231:Infant, Newborn; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D002679:Pan troglodytes; D011247:Pregnancy; D012449:Safety; D014611:Vaccination; D019444:Vaccines, DNA / Q000191:economics / Q000276:immunology; D014614:Vaccines, Synthetic / Q000191:economics / Q000276:immunology
D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic